Literature DB >> 19450298

Sleep disorders in children.

Paul Montgomery1, Danielle Dunne.   

Abstract

INTRODUCTION: Sleep disorders may affect 20-30% of young children, and include excessive daytime sleepiness, problems getting to sleep (dysomnias), or undesirable phenomena during sleep (parasomnias), such as sleep terrors, and sleepwalking. Children with physical or learning disabilities are at increased risk of sleep disorders. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of treatments for dysomnias in children? What are the effects of treatments for parasomnias in children? We searched: Medline, Embase, The Cochrane Library and other important databases up to September 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 14 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: antihistamines, behavioural therapy plus benzodiazepines, or plus chloral and derivates, exercise, extinction and graduated extinction, light therapy, melatonin, safety/protective interventions for parasomnias, scheduled waking (for parasomnias), sleep hygiene, and sleep restriction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19450298      PMCID: PMC2943792     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  35 in total

1.  Maternal, environmental, and temperamental characteristics of toddlers with and toddlers without sleep problems.

Authors:  K R Jimmerson
Journal:  J Pediatr Health Care       Date:  1991 Mar-Apr       Impact factor: 1.812

2.  Pro-convulsant effects of oral melatonin in neurologically disabled children.

Authors:  S H Sheldon
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

Review 3.  Safety of melatonin in long-term use (?)

Authors:  J Arendt
Journal:  J Biol Rhythms       Date:  1997-12       Impact factor: 3.182

Review 4.  Reproductive safety of melatonin: a "wonder drug" to wonder about.

Authors:  D R Weaver
Journal:  J Biol Rhythms       Date:  1997-12       Impact factor: 3.182

5.  Severe sleep disturbance and daytime challenging behaviour in children with severe learning disabilities.

Authors:  L Wiggs; G Stores
Journal:  J Intellect Disabil Res       Date:  1996-12

6.  Sleep problems in toddlers: effects of treatment on their daytime behavior.

Authors:  K Minde; A Faucon; S Falkner
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994-10       Impact factor: 8.829

7.  Inability of clinical history to distinguish primary snoring from obstructive sleep apnea syndrome in children.

Authors:  J L Carroll; S A McColley; C L Marcus; S Curtis; G M Loughlin
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

8.  Reducing sleep disruptions in young children: evaluation of therapist-guided and written information approaches: a brief report.

Authors:  F W Seymour; P Brock; M During; G Poole
Journal:  J Child Psychol Psychiatry       Date:  1989-11       Impact factor: 8.982

9.  Correlations between night sleep duration and seizure frequency in temporal lobe epilepsy.

Authors:  P Rajna; J Veres
Journal:  Epilepsia       Date:  1993 May-Jun       Impact factor: 5.864

Review 10.  Sleep disorders in children.

Authors:  J A Mindell
Journal:  Health Psychol       Date:  1993-03       Impact factor: 4.267

View more
  1 in total

1.  Prevalence and persistence of sleep disordered breathing symptoms in young children: a 6-year population-based cohort study.

Authors:  Karen A Bonuck; Ronald D Chervin; Timothy J Cole; Alan Emond; John Henderson; Linzhi Xu; Katherine Freeman
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.